Although genomic analyses showed that K-Ras mutations occur in ~20% of CCA15, sustained activation of MEK/ERK downstream effectors was detected in most CCA10, implying induction of this oncogenic cascade mainly in the presence of wild-type K-Ras in this tumor type. The gene discussed is KRAS; the disease is neoplasm.